Strategy | Financing Transactions Private Placement / Financing Transactions Seaport Therapeutics: The company raised $225 million of Series B venture funding in a deal led by General Atlantic, Arch Venture Partners, and Sofinnova Investments on October 21, 2024,...
Strategy | Financing Transactions Private Placement / Financing Transactions Terray Therapeutics: The company raised $120 million of Series B venture funding in a deal led by NVentures and Bedford Ridge Capital on October 17, 2024, putting the company’s...
Strategy | Financing Transactions Private Placement / Financing Transactions City Therapeutics: The company raised $135 million of Series A venture funding in a deal led by ARCH Venture Partners on October 8, 2024. Regeneron Ventures, The Invus Group, AN Ventures,...
Strategy | Financing Transactions Private Placement / Financing Transactions Aktis Oncology: The company raised $175 million of Series B venture funding in a deal led by RA Capital Management, RTW Investments and Janus Henderson Investors on September 30, 2024. MRL...
trategy | Financing Transactions Private Placement / Financing Transactions EGYM: The company raised an estimated $200 million of Series G venture funding led by L Catterton with participation from Meritech Capital Partners on September 24, 2024, putting the...
Strategy | Financing Transactions Private Placement / Financing Transactions Nura Bio: The company raised $141 million of Series A venture funding in a deal led by The Column Group on September 17, 2024, putting the company’s pre-money valuation at $35 million....
